Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2025-12-24 @ 10:13 PM
NCT ID:
NCT01233635
Eligibility Criteria:
Inclusion Criteria:
* Subjects must be in atrial fibrillation confirmed by 12 lead EKG.
* blood pressure \> 90 mmHg
* Patient without cardiopulmonary symptoms
* 18+ years of age
Exclusion Criteria:
* Contraindiction to warfarin
* Recent (within 6 months) MI or cardiac revascularization
* Recent (within 6 months) CVA or TIA
* NYHA Class IV CHF
* Active thyroid disease
* Major hepatic dysfunction
* Renal dysfunction (\>2 mg/dL)
* Hyperkalemia (\>4.6 mEq/L)
* Hyponatremia (\<130 mEq/L)
* Currently taking a Vaughn-Williams Type I or III antiarrhythmic drug
* History of ARB intolerance
* Contraindication to ARB therapy
* Pregnancy
* Female of childbearing age
* Age \< 18 years of age
* Inability to give informed consent
* Other medical conditions calling 1 year survival into question
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01233635
Study Brief:
Protocol Section:
NCT01233635